Alkem Laboratories Completes 100% Acquisition of Adroit Biomed, Bolstering Growth in Indian Pharmaceutical Sector: Stock Gains 3%
Mumbai, April 23, 2025 – Alkem Laboratories Limited (NSE: ALKEM, BSE: 539523), a leading Indian pharmaceutical giant, has successfully completed its 100% acquisition of Adroit Biomed
Read More